Sun, Apr 20, 2014, 11:27 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Staples, Inc. Message Board

gswkool 65 posts  |  Last Activity: 18 hours ago Member since: Jan 2, 2012
  • Reply to

    After conference... UP wil go

    by betobetunjr Feb 13, 2014 5:16 PM
    gswkool gswkool Feb 16, 2014 12:50 PM Flag

    I think it's obvious that big pharma doesn't like risk. They are afraid of making a bad move, being questioned and maybe jeopardizing their job positions. They wait and wait until the technology is proven before making a purchase. By that time the price tag is way up there. ALNY platform needs to be validated further by big pharma before they make their move. It's about the platform. Anyhow, their loss / inaction is small investors' gain. Those are my thoughts, anyhow...

  • Reply to

    After conference... UP wil go

    by betobetunjr Feb 13, 2014 5:16 PM
    gswkool gswkool Feb 15, 2014 10:19 AM Flag

    silly reaction to earnings. they will have plenty of cash on hand at end of 2014 and their pipeline development is going well. this company is gonna be very big one day if it doesn't get bought out. A smart pharma would have already bought it when it was a billion and change....now look at the price tag...

  • Reply to

    Waiting on HD Results to Re-Enter

    by dmj3430 Feb 15, 2014 1:19 AM
    gswkool gswkool Feb 15, 2014 10:14 AM Flag

    Agree with your assessment - I played it similarly to a point. However, as of yesterday I bought a little back from my profit. Now playing with house money. I'm not expecting much out of HD results. I think the risk/reward is better with AD. I'm willing to take a little hit on some of my profits if the response to HD is negative. If the stock jumps from here, I will hold what I have. If it falls further after HD, I will buy a little more to dollar cost average.....and hope for the best. I do think small biotech has better shot than big pharma, which has failed miserably with AD. This drug is very different, and has different theory behind it...who knows...hopefully get lucky......GLTA

  • Reply to

    nobody knows

    by gswkool Feb 11, 2014 11:06 PM
    gswkool gswkool Feb 12, 2014 8:26 PM Flag

    What I was saying is that if you at least sold some so that you will walk away with a profit regardless of what the stock does in the future, then you are still a winner. You may not feel like one when the remainder of your holding goes down -but a profit is a profit. I know psychologically, though, it's hard for our minds to put things in perspective. When you go to a casino and you win a little money, you don't get much of an uplift or are ambivalent. However, if you lose that same amount, you feel pretty lousy. Anyhow, didn't mean to be insensitive...sorry for your losses....

  • gswkool by gswkool Feb 11, 2014 11:06 PM Flag

    if it works or not...not at this point. Can argue or guess...what's the point.....and if it does turn out to work - it may work for reasons other than what was expected. It may work for reasons that are not even understood. If you were smart, by now you got your triple and are playing with the house's money. In which case, you can't loose...GLTA

  • EYLEA Ph III success treating DME. I suppose as more treatments come out to treat DME this will take away from potential pool of people who will qualify for Lluvien, as it is getting positioned as a treatment of last resort. On the other hand, EYLEA offers another opportunity for partnership for PSDV delivery technology. I much rather be in PSDV than ALIM........comments...opinions.....welcome......GLTA

  • gswkool gswkool Feb 9, 2014 10:32 AM Flag

    Na, -nothing is amiss. Seen this sell the news behavior over and over -just momentum traders in it for the quick buck getting out before the news....no biggie if you are in it for the big payoff at the end of the rainbow...

  • Reply to

    BL 8040 Rocks NY

    by feelthesurg Feb 5, 2014 2:09 PM
    gswkool gswkool Feb 8, 2014 12:15 PM Flag

    attending a lot of conferences is good for this Company -hopefully leads to interest and more deals/partnerships for its growing pipeline.....

  • Reply to

    Any other good speculative bio techs.

    by jgraham192 Feb 8, 2014 8:17 AM
    gswkool gswkool Feb 8, 2014 12:07 PM Flag

    Well, at least this post isn't about politics..... Personally, been doing real well in biotech but this year the market has been risk off. So, spec biotechs have been exposed to profit taking out of fear. Can't blame em. Anyhow, I still hold shares in a bunch of them as well as few med device co's including PSDV, GERN, BLRX, NVAX, SVA, ALNY, ISIS, RGDO, ROSG, NKTR, CERS, CCXI, VICL, PRAN, as well as a stem cell basket - ATHX, MBLTY, OSIR, NBS, KOOL and lastly ACTC. I buy a diverse basket as I don't know who will wind and who will lose. My favortes are PSDV, GERN, and BLRX. I believe they have room to run this year. PRAN has news coming in I believe March. It's an Australian company working on Alzheimers and Huntingtons. High risk and high reward.....good luck

  • Reply to

    Now that

    by gswkool Feb 5, 2014 6:37 PM
    gswkool gswkool Feb 8, 2014 11:50 AM Flag

    or maybe they can do a deal with the #$%$ distributors like they did with Kelloggs - how bout Chocolate Macadamia Reefer.....

  • gswkool by gswkool Feb 8, 2014 11:24 AM Flag

    tech evals strung out for years by sub-par companies, who end up going bust or getting bought out for pennies on the dollar before anything material emerges. I don't believe that will be the case here with Tethadur. I'm not worried but I will certainly be happy to see some data come out. I do believe the company will be revalued if the data comes out and is promising. I could see the stock up at least another 50% .....GLTA

  • gswkool gswkool Feb 6, 2014 9:56 PM Flag

    I expect it to be a boring conf call with very little new in way of news. Personally, I don't like it when companies choose Fridays after the bell for their conf calls. Some #$%$ companies i invested in the past tried to slip news by on Fri after the bell. I really doubt that will be the case with PSDV. A boring review of financials and repeat of old news, -that's what I expect. The real news will come out with separate PR and in reviews of new data at conferences....as for the recent decline in price, -simply momentum players off chasing other stocks and others with some fear of losing the big gains in PSDV this past year selling theirs. They can't have mine.....cheaply that is....

  • Reply to

    The Blind Cashier

    by jnichols_962711 Feb 5, 2014 6:06 PM
    gswkool gswkool Feb 5, 2014 6:43 PM Flag

    if a fetus passes wind in utero, does it still make a sound?

  • gswkool by gswkool Feb 5, 2014 6:37 PM Flag

    pot is legal in Colorado, does anyone see any new, original flavors coming out of RMCF?

  • gswkool gswkool Feb 2, 2014 4:25 PM Flag

    I give the edge to Broncos as well, but I think the Broncos will not score 41. I think it will be more like 24 to 16.....in other words bet the UNDER and take the BRONCOS.....

  • gswkool gswkool Feb 1, 2014 4:10 PM Flag

    most drugs fail so if you are an analyst you bet on failure and you will be right more than you will be wrong. It makes you look smart. In reality, most opinions are worthless. I don't know what the result will be. If you can't stand to lose, take your chips off the table....

  • Reply to

    Question for Stem Cell Longs

    by mikefgadams Jan 31, 2014 10:25 PM
    gswkool gswkool Feb 1, 2014 4:00 PM Flag

    ACTC just dumped their CEO. Company mismanaged for quite some time. Maybe the science works,maybe it doesn't. If you believe stem cells can treat many diseases, in my humble opinion it's best to buy a basket of stocks in the space. Who knows which company will succeed and which will fail in the end, -what I do know is that there will be both winners and losers. My basket is ATHX, PSTI, NBS, OSIR, ACTC, KOOL, and MBLTY. My KOOL just doubled so I sold half and used the profit to buy MBLTY. I also have some interest in stem cells through ownership of GERN, which has interest in Biotime. Of the stocks mentioned above, the ones with big market cap are MBLTY & OSIR. They are more of the bellweathers....GLTA

  • gswkool by gswkool Jan 27, 2014 8:36 PM Flag

    Let me know when we have some new data....

  • Reply to

    RGDO holders check out PTLA. Opinions?

    by gswkool Jan 13, 2014 8:54 PM
    gswkool gswkool Jan 26, 2014 1:26 PM Flag

    They got PH2 results. I think they are ahead or on par with RGDO. They also have big market cap. "Portola Pharmaceuticals Announces New Phase 2 Results Confirming Immediate, Dose-Dependent and Well-Tolerated Reversal of Anticoagulation Activity of XARELTO(R) (rivaroxaban) With Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Reversal Agent" posted Dec 9th.
    If they were close in market cap I would invest in both. I think only one will be the winner and I'm not convinced I picked the right one -I certainly picked the cheaper one and the one with more significant upside potential due to low price.... I dunno....

  • Reply to

    Harder to hold going up

    by fowen Jan 22, 2014 2:03 PM
    gswkool gswkool Jan 26, 2014 1:00 PM Flag

    hear you loud and clear....In the past when a stock climbed I would sell some amount of shares each time it climbed. I didn't want to lose. Unfortunately, I chose that strategy with a little company called Intuitive Surgical. It was little when I bought the shares, anyway. If I had done the opposite, and bought more as it moved up, I would be retired on the beach somewhere typing this. So now if I have absolute conviction in a company, I buy more on the dips instead of selling on moves higher. Key is absolute conviction. .....and that has to come from you and no one else....GLTA

SPLS
12.03+0.14(+1.18%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.